Annual Total Long Term Liabilities
$111.00 K
+$39.90 K+56.12%
31 December 2023
Summary:
BioNexus Gene Lab annual total long term liabilities is currently $111.00 thousand, with the most recent change of +$39.90 thousand (+56.12%) on 31 December 2023. During the last 3 years, it has risen by +$31.50 thousand (+39.62%). BGLC annual total long term liabilities is now at all-time high.BGLC Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$192.00 K
-$2600.00-1.34%
30 September 2024
Summary:
BioNexus Gene Lab quarterly total long term liabilities is currently $192.00 thousand, with the most recent change of -$2600.00 (-1.34%) on 30 September 2024. Over the past year, it has increased by +$58.30 thousand (+43.61%). BGLC quarterly long term liabilities is now -1.34% below its all-time high of $194.60 thousand, reached on 30 June 2024.BGLC Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BGLC Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +56.1% | +43.6% |
| 3 y3 years | +39.6% | +191.3% |
| 5 y5 years | +93.7% | +235.1% |
BGLC Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +68.4% | -1.3% | +383.6% |
| 5 y | 5 years | at high | +93.7% | -1.3% | +383.6% |
| alltime | all time | at high | +93.7% | -1.3% | +383.6% |
BioNexus Gene Lab Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $192.00 K(-1.3%) |
| June 2024 | - | $194.60 K(+93.1%) |
| Mar 2024 | - | $100.80 K(-9.2%) |
| Dec 2023 | $111.00 K(+56.1%) | $111.00 K(-17.0%) |
| Sept 2023 | - | $133.70 K(+127.8%) |
| June 2023 | - | $58.70 K(-11.6%) |
| Mar 2023 | - | $66.40 K(-6.6%) |
| Dec 2022 | $71.10 K(+7.9%) | $71.10 K(+79.1%) |
| Sept 2022 | - | $39.70 K(-10.8%) |
| June 2022 | - | $44.50 K(-28.9%) |
| Mar 2022 | - | $62.60 K |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $65.90 K(-17.1%) | - |
| Dec 2021 | - | $65.90 K(+35.6%) |
| Sept 2021 | - | $48.60 K(-17.8%) |
| June 2021 | - | $59.10 K(-16.4%) |
| Mar 2021 | - | $70.70 K(-11.1%) |
| Dec 2020 | $79.50 K(+38.7%) | $79.50 K(+82.8%) |
| Sept 2020 | - | $43.50 K(-1.4%) |
| June 2020 | - | $44.10 K(-5.8%) |
| Mar 2020 | - | $46.80 K(-18.3%) |
| Dec 2019 | $57.30 K(-15.0%) | $57.30 K |
| Dec 2018 | $67.40 K | - |
FAQ
- What is BioNexus Gene Lab annual total long term liabilities?
- What is the all time high annual total long term liabilities for BioNexus Gene Lab?
- What is BioNexus Gene Lab annual total long term liabilities year-on-year change?
- What is BioNexus Gene Lab quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for BioNexus Gene Lab?
- What is BioNexus Gene Lab quarterly long term liabilities year-on-year change?
What is BioNexus Gene Lab annual total long term liabilities?
The current annual total long term liabilities of BGLC is $111.00 K
What is the all time high annual total long term liabilities for BioNexus Gene Lab?
BioNexus Gene Lab all-time high annual total long term liabilities is $111.00 K
What is BioNexus Gene Lab annual total long term liabilities year-on-year change?
Over the past year, BGLC annual total long term liabilities has changed by +$39.90 K (+56.12%)
What is BioNexus Gene Lab quarterly total long term liabilities?
The current quarterly long term liabilities of BGLC is $192.00 K
What is the all time high quarterly long term liabilities for BioNexus Gene Lab?
BioNexus Gene Lab all-time high quarterly total long term liabilities is $194.60 K
What is BioNexus Gene Lab quarterly long term liabilities year-on-year change?
Over the past year, BGLC quarterly total long term liabilities has changed by +$58.30 K (+43.61%)